• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Technology
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
    • SUO Corner
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Antibiotics Show Limited Effectiveness in Eosinophilic CRS-Associated Inflammation

by Amy E. Hamaker • April 21, 2017

  • Tweet
  • Email a link to a friend (Opens in new window) Email
Print-Friendly Version

Are antibiotics an appropriate maximal medical therapy for the CRS subtype eosinophilic chronic rhinosinusitis (eCRS)?

Bottom line
The use of antibiotics without independent anti-inflammatory properties has limited efficacy in patients with eCRS.

You Might Also Like

  • Eosinophilic Esophagitis, CRS Show Associations as Comorbid Conditions
  • SEMA4D Exacerbates Eosinophilic CRS in Humans, Mice
  • Intranasal Corticosteroids Improve Asthma Symptoms in CRS
  • For Chronic Sinusitis, Give Antibiotics a Longer Chance to Work Before Surgery
Explore This Issue
April 2017

Background: Advances in our understanding of the immunological processes underpinning CRS suggest that different subtypes exist. One subtype, eCRS, comprises T-helper cell type 2 (Th2) inflammation and local eosinophilic tissue infiltration, but its etiology remains elusive. Most clinicians continue to prescribe antimicrobial therapy that lacks any secondary anti-inflammatory properties for all patients with any CRS form.

Study design: Prospective individual cohort study of 39 patients presenting with CRS.

Setting: Department of Otolaryngology–Head and Neck Surgery, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

Synopsis: Patients had a mean age of 37.40 ± 13.45 years. Twenty-five patients were classified as eCRS and 14 as non-eCRS based on their histopathological analysis. All patients underwent endoscopic sinus surgery (ESS) after previous medical therapy. Amoxicillin–clavulanic acid was used as it is one of the most common first-line CRS antibiotic choices but does not have any known independent anti- inflammatory properties, and concomitant use of oral or topical steroids was excluded. Upon comparative analysis between the two subgroups, there were no differences with respect to asthma, aspirin hypersensitivity, or smoking. Both pre- and post-treatment Lund-Mackay, and pre-treatment Lund-Kennedy scores were significantly worse in the eCRS group compared to the non-eCRS group, whereas the Sino-Nasal Outcome Test (SNOT-22) score was comparable. Following treatment, the non-eCRS group demonstrated significant improvement in both the Lund-Mackay score and SNOT-22 score, but not the Lund-Kennedy score. The eCRS patients demonstrated improvement only in their Lund-Mackay scores. A higher number of revision surgeries and worse pre-treatment Lund-Mackay scores were found in the eCRS group.

Citation: Günel C, Bleier BS, Meteoglu I. Antibiotics in eosinophilic chronic rhinosinusitis: Rethinking maximal antimicrobial medical therapy. Laryngoscope. 2017;127:794–796.

Filed Under: Literature Reviews, Rhinology Tagged With: antibiotics, CRS, eCRS, inflammation, treatmentIssue: April 2017

You Might Also Like:

  • Eosinophilic Esophagitis, CRS Show Associations as Comorbid Conditions
  • SEMA4D Exacerbates Eosinophilic CRS in Humans, Mice
  • Intranasal Corticosteroids Improve Asthma Symptoms in CRS
  • For Chronic Sinusitis, Give Antibiotics a Longer Chance to Work Before Surgery

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you ever participated in a professional group's advocacy or Hill Day event?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Is the SLOR in Otolaryngology Residency Applications Contributing to Rural Disparities?
  • Applications Open for Resident Members of the ENTtoday Editorial Board: Deadline Extended
  • A Resident’s View of AI in Otolaryngology
  • Call for Resident Bowl Questions
  • Resident Pearls: Pediatric Otolaryngologists Share Tips for Safer, Smarter Tonsillectomies
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Royal Family Heritage: The Habsburg Jaw
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • What Does The Pitt Have Against Otolaryngologists?
    • History of the Cochlear Implant
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment
    • Complications for When Physicians Change a Maiden Name
    • Society Debuts TRIO Leadership Academy
    • Innovations in Otolaryngology: Two Paths to Progress
    • How to Have Effective Presurgical Discussions
    • Advocacy: Finding Our Voice
    • A Royal Family Heritage: The Habsburg Jaw

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939